Michael has more than 25 years of strategy and finance experience, including over 20 years of experience in product strategy, product launch, competitive strategy and portfolio strategy. He is a strategic advisor to life sciences companies, bringing experience across most therapeutic areas, as well as complex specialty products and cell and gene therapy. Michael was previously a partner with several strategy consulting firms, including Campbell Alliance (now Syneos Health), where he led commercial strategy for the Eastern U.S. and led launch globally. He has successfully delivered 400+ strategy engagements with life sciences clients throughout his career. He received a M.B.A. from Ross School of Business at University of Michigan and a B.S. in Engineering from Cornell University.